Jürgen Rockstroh is Professor of Medicine and Head of the HIV Outpatient Clinic at the University of Bonn in Germany. In addition to his clinical practice, Dr Rockstroh is involved in HIV research on: antiretroviral therapy, including new drug classes; the course of HIV disease in hemophiliacs; and HIV and hepatitis co-infection. He was the Chairman of the German Clinical AIDS Working Group (KAAD) from 1998 to 2007, was elected as the president of the German AIDS Society from 2007 to 2011, and, since 2009, he is also a member of the executive committee of the European AIDS Clinical Society (EACS). He chaired the organizing committee for the First and Second International Workshops on HIV and Hepatitis Co-Infection in 2004 and 2005 in Amsterdam, and was on the international organizing committee for the First European Consensus Conference on the Treatment of Chronic Hepatitis B and C in HIV Co-Infected Patients in 2005. He currently chairs the hepatitis research activities in the European AIDS Treatment Network (NEAT) and EuroSIDA.
At the completion of this educational session, learners will:
- Be familiar with the current treatment algorithms for HCV therapy in HIV coinfection.
- Be able to identify suitable candidates for treatment of HCV with underlying HIV coinfection.
- Know current DAA based treatment approaches for HCV with HIV coinfection.
- Be aware of prediction factors for HCV treatment response as well as presentation of adverse event management.
This CME activity was approved for
AMA PRA Category 1 Credit™ on June 18, 2014 and will terminate June, 2017.
The target audience is all physicians, NPs and PAs involved or interested in HIV education.
This online video and post-activity evaluation are one hour in length.
After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
You must achieve at least 70% correct to receive your CME certificate.
If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Society of the State of New York designates this enduring material for a maximum of 1.0
AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with extent of their participation in the activity.
Policies and standards of MSSNY require that speakers and planners for CME activities disclose any relevant financial relationships they may have with commercial interests whose products, devices or services may be discussed in the content of a CME activity.
Dr. James Braun (Planner/Course Director) had no relevant financial relationships to disclose.
Dr. Rockstroh (Presenter) has had the following personal financial relationships in the past 12 months with manufacturers of the products or services that may be presented in this CME activity: Consultancy for AbbVie, Bionor, BMS, Boehringer Ingelheim, Gilead, GSK, MSD, Novartis, Pfizer, Roche, Tibotec, and ViiV; grants from AbbVie, and Merck. Dr. Rockstroh will support his presentation and clinical recommendations with the best available evidence from the medical literature, and will submit his slides in advance for adequate peer review.
This PRN CME activity is funded in part by unrestricted educational grants from:
Bristol-Myers Squibb, Gilead Sciences, Janssen Pharmaceuticals, Merck & Co, and ViiV Healthcare.
To obtain CME credit for this PRN program, please visit the
PRN Courses page at the Clinical Education Initiative (CEI) web site. PRN and the Medical Society of the State of New York (MSSNY) jointly sponsor PRN enduring materials for CME, and provide them at no cost to the AIDS Institute of the New York State Department of Health (NYSDOH) for broadcast through the CEI. We thank the NYSDOH for making our CME programs available to a wider audience, and hope you will also browse the many other educational opportunities offered by the CEI.
